Correlation Between Fennec Pharmaceuticals and MediciNova

Can any of the company-specific risk be diversified away by investing in both Fennec Pharmaceuticals and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fennec Pharmaceuticals and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fennec Pharmaceuticals and MediciNova, you can compare the effects of market volatilities on Fennec Pharmaceuticals and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fennec Pharmaceuticals with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fennec Pharmaceuticals and MediciNova.

Diversification Opportunities for Fennec Pharmaceuticals and MediciNova

-0.35

Correlation Coefficient

Fennec Pharmaceuticals  MediciNova

Very good diversification

The 3 months correlation between Fennec and MediciNova is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Fennec Pharmaceuticals and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Fennec Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fennec Pharmaceuticals are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Fennec Pharmaceuticals i.e., Fennec Pharmaceuticals and MediciNova go up and down completely randomly.

Pair Corralation between Fennec Pharmaceuticals and MediciNova

Given the investment horizon of 90 days Fennec Pharmaceuticals is expected to generate 0.94 times more return on investment than MediciNova. However, Fennec Pharmaceuticals is 1.07 times less risky than MediciNova. It trades about 0.05 of its potential returns per unit of risk. MediciNova is currently generating about -0.2 per unit of risk. If you would invest  616.00  in Fennec Pharmaceuticals on December 30, 2024 and sell it today you would earn a total of  34.00  from holding Fennec Pharmaceuticals or generate 5.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Fennec Pharmaceuticals  vs.  MediciNova

Fennec Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Fennec Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Fennec Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

MediciNova

Risk-Adjusted Performance

Very Weak

Over the last 90 days MediciNova has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Fennec Pharmaceuticals and MediciNova

The main advantage of trading using opposite Fennec Pharmaceuticals and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fennec Pharmaceuticals position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.

The idea behind Fennec Pharmaceuticals and MediciNova pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.